GB0424624D0 - Selective chemotherapy of malignant cancer cells - Google Patents
Selective chemotherapy of malignant cancer cellsInfo
- Publication number
- GB0424624D0 GB0424624D0 GB0424624A GB0424624A GB0424624D0 GB 0424624 D0 GB0424624 D0 GB 0424624D0 GB 0424624 A GB0424624 A GB 0424624A GB 0424624 A GB0424624 A GB 0424624A GB 0424624 D0 GB0424624 D0 GB 0424624D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer cells
- malignant cancer
- selective chemotherapy
- chemotherapy
- selective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000002512 chemotherapy Methods 0.000 title 1
- 230000003211 malignant effect Effects 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424624A GB0424624D0 (en) | 2004-11-06 | 2004-11-06 | Selective chemotherapy of malignant cancer cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424624A GB0424624D0 (en) | 2004-11-06 | 2004-11-06 | Selective chemotherapy of malignant cancer cells |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0424624D0 true GB0424624D0 (en) | 2004-12-08 |
Family
ID=33523338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0424624A Ceased GB0424624D0 (en) | 2004-11-06 | 2004-11-06 | Selective chemotherapy of malignant cancer cells |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0424624D0 (en) |
-
2004
- 2004-11-06 GB GB0424624A patent/GB0424624D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1102757A1 (en) | Therapy of platinum-resistant cancer | |
HK1077583A1 (en) | Cudr as biomarker for cancer progression and therapeutic response | |
HK1231521A1 (en) | Prediction of likelihood of cancer recurrence | |
IL179812A0 (en) | THE IMPORTANCE OF THE GENE HoxB13 FOR CANCER | |
FR2872704B1 (en) | PLURITHERAPY AGAINST CANCER | |
EP1697497A4 (en) | Liver cancer biomarkers | |
EP1749827A4 (en) | Anti-tumor agent | |
EP2121988A4 (en) | Prostate cancer survival and recurrence | |
PL1858929T3 (en) | Diagnosis of prostate cancer | |
EP1891047A4 (en) | 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents | |
IL186980A0 (en) | Characterizing prostate cancer | |
GB0421838D0 (en) | Cancer markers | |
HK1108924A1 (en) | Cancer prognostic methods | |
GB0417740D0 (en) | Methods and kit for the prognosis of breast cancer | |
EP1773883A4 (en) | Antibodies against cancer produced using masked cancer cells as immunogen | |
EP1625853A4 (en) | Apoptosis inducer for cancer cell | |
GB0405258D0 (en) | Selective chemotherapy of malignant cancer cells | |
GB0424624D0 (en) | Selective chemotherapy of malignant cancer cells | |
EP1783231A4 (en) | Method of judging grade of malignancy of carcinoma cell | |
EP1595546A4 (en) | REMEDY AGAINST CANCER | |
EP1731160A4 (en) | Cancer metastasis inhibitory composition | |
PL367652A1 (en) | Compound for initiating apoptosis of cancer cells | |
SE0400805D0 (en) | Cancer chemotherapy | |
GB0428313D0 (en) | Assessment of prostate cancer | |
GB0407587D0 (en) | Cancer associated antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |